These findings were consistent with the presence of the CTNNB1 c.14-10_241+25del variant at VAF 5% and 26% in HB and HCC-like components, respectively, and IHC protein expression, which showed strong cytoplasmic and focal nuclear β-catenin expression in the HCC-like component. Here, CTNNB1 is linked to hepatocellular carcinoma.